Drug copies ready to take next bite out of Roche's cancer sales

LONDON (Reuters) – European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *